(Q24301122)

glucose metabolic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

7

D Molnár

0 references

author name string

E Lányi

1

0 references

K Csernus

2

0 references

E Erhardt

3

0 references

K Tóth

4

0 references

B Urbán

5

0 references

L Lénárd

Journal of Endocrinological Investigation

6

0 references

language of work or name

English

0 references

publication date

February 2007

0 references

published in

0 references

volume

30

0 references

issue

2

0 references

page(s)

133-7

0 references

cites work

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Endocrine and non-endocrine actions of ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Effect of oral glucose administration on ghrelin levels in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

The homeostasis model in the San Antonio Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347411

Differential effects of high-fat and high-carbohydrate content isoenergetic meals on plasma active ghrelin concentrations in lean and obese women

21 January 2018

1 reference

12 December 2020

Food fails to suppress ghrelin levels in obese humans.

1 reference

12 December 2020

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

1 reference

12 December 2020

The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors

1 reference

12 December 2020

Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors

1 reference

12 December 2020